Application of a prescribing indicators tool to assist in identifying drug-related problems in a cohort of older Australians

International Journal of Pharmacy Practice

Volumn 20, Issue 3, 2012, Pages 172-182

  Basger, Benjamin J ^a   Chen, Timothy F ^a   Moles, Rebekah J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

decision support tool; drug related problems; inappropriate drug use; older patients; under treatment

Indexed keywords

ANALGESIC AGENT; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PRESCRIPTION DRUG;

AGED; ARTICLE; AUSTRALIA; COHORT ANALYSIS; DRUG USE; ELDERLY CARE; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PAIN; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PRIVATE HOSPITAL; UNSPECIFIED SIDE EFFECT;

AGED; AGED, 80 AND OVER; AUSTRALIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DRUG INTERACTIONS; DRUG UTILIZATION; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; PHARMACEUTICAL PREPARATIONS;

EID: 84860640387     PISSN: 09617671     EISSN: 20427174     Source Type: Journal    
DOI: 10.1111/j.2042-7174.2011.00177.x     Document Type: Article

References (86)

1. Castelino RL, et al,. Use of evidence-based therapy for the prevention of cardiovascular events among older people. Eval Health Prof 2010; 33(3): 276-301.
2. Heeley EL, et al,. Cardiovascular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study). Med J Aust 2010; 192: 254-259.
3. Higashi T, et al,. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 2004; 140: 714-720.
4. Hilmer SN, Gnjidic D,. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009; 85: 86-88.
5. Hollingworth SA, et al,. Secondary prevention of osteoporosis in Australia. Drugs Aging 2010; 27: 255-264.
6. Pratt N, et al,. Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations. Drugs Aging 2010; 27: 63-71.
7. PCNE Foundation. The PCNE Classification V 6.2. Pharmaceutical Care Network Europe Foundation. 2010. www.pcne.org/sig/drp/documents/drp/ PCNE%20classification%20V6-2.pdf (accessed 14 October 2011).
8. Kwint H-F, et al,. Effects of medication review on drug-related problems in patients using automated drug-dispensing systems. Drugs Aging 2011; 28: 305-314.
9. Krass I, Smith C,. Impact of medication regimen reviews performed by community pharmacists for ambulatory patients through liaison with general medical practitioners. Int J Pharm Pract 2000; 8: 111-120.
10. Ellitt GR, et al,. Drug related problems after discharge from an Australian teaching hospital. Pharm World Sci 2010; 32(5): 622-630.
11. Nishtala PS, et al,. A retrospective study of drug-related problems in Australian aged care homes: medication reviews involving pharmacists and general practitioners. J Eval Clin Pract 2011; 17: 97-103.
12. Stafford AC, et al,. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci 2009; 31: 216-223.
13. Laroche ML, et al,. Inappropriate medications in the elderly. Clin Pharmacol Ther 2009; 85: 94-97.
14. Kaur S, et al,. Interventions that can reduce inappropriate prescribing in the elderly. Drugs Aging 2009; 26: 1013-1028.
15. Chang C-B, Chan D-C,. Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs Aging 2010; 27: 947-957.
16. Castelino RL, et al,. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother 2009; 43: 1096-1106.
17. Scott I, Jayathissa S,. Quality of drug prescribing in older patients: is there a problem and can we improve it? Intern Med J 2010; 40: 7-18.
18. Fick DM, et al,. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724.
19. Gallagher P, et al,. STOPP (screening tool of older person's prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72-83.
20. Holt S, et al,. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 2010; 107: 543-551.
21. Laroche ML, et al,. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007; 63: 725-731.
22. Tulner LR, et al,. Changes in under-treatment after comprehensive geriatric assessment. An observational study. Drugs Aging 2010; 27: 831-843.
23. Garfinkel D, Mangin D,. Feasibility study of a systemic approach for discontinuation of multiple medications in older adults. Arch Intern Med 2010; 170: 1648-1654.
24. O'Connor PJ, et al,. Impact of elecronic health record clinical decision support on diabetes care; a randomised trial. Ann Fam Med 2011; 9: 12-21.
25. Gill JM, et al,. Impact of EHR-based clinical decision support on adherence to guidelines for patients on NSAID's: a randomised controlled trial. Ann Fam Med 2011; 9: 22-30.
26. Nishtala PS, et al,. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16: 621-632.
27. Blix HS, et al,. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci 2006; 28: 152-158.
28. Vinks THAM, et al,. Pharmacist-based medication review reduces potential drug-related problems in the elderly. Drugs Aging 2009; 26: 123-133.
29. Gomez MA, et al,. Promoting appropriate drug use through the application of the Spanish drug-related problem classification system in the primary care setting. Ann Pharmacother 2009; 43: 339-346.
30. Sorensen L, et al,. Medication reviews in the community: results of a randomised, controlled effectiveness trial. Br J Clin Pharmacol 2004; 58: 648-664.
31. Castelino RL, et al,. Drug burden index and potentially inappropriate medications in community-dwelling older people. Drugs Aging 2010; 27: 135-148.
32. Gilbert AL, et al,. Collaborative medication management services: improving patient care. Med J Aust 2002; 177: 189-192.
33. Castelino RL, et al,. Are interventions recommended by pharmacists during Home Medicines Review evidence-based? J Eval Clin Pract 2010; 17(1): 104-110.
34. Granas AG, et al,. Evaluating categorisation and clinical relevance of drug-related problems in medication reviews. Pharm World Sci 2010; 32: 394-403.
35. Laaksonen R, et al,. Performance of community pharmacists in providing clinical medication reviews. Ann Pharmacother 2010; 44: 1181-1190.
36. Lau E, Dolovich LR,. Drug-related problems in elderly general practice patients receiving pharmaceutical care. Int J Pharm Pract 2005; 13: 165-177.
37. Hammerlein A, et al,. Survey of drug-related problems identified by community pharmacies. Ann Pharmacother 2007; 41: 1825-1832.
38. Krska J, Avery AJ,. Evaluation of medication reviews conducted by community pharmacists: a quantitative analysis of documented issues and recommendations. Br J Clin Pharmacol 2007; 65: 386-396.
39. Basger BJ, et al,. Inappropriate medication use and prescribing indicators in elderly Australians. Drugs Aging 2008; 25: 777-793.
40. Vitry AI, Zhang Y,. Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions. Med J Aust 2008; 189: 360-365.
41. O'Mahony D, Gallagher PF,. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008; 37: 138-141.
42. Steinman MA, et al,. Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing. Arch Intern Med 2009; 169: 1326-1332.
43. Dimitrow MS, et al,. Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: A systematic review. J Am Geriatr Soc 2011; 59(8): 1521-1530.
44. Access to Pharmaceutical Services. Pharmaceutical Benefits Scheme Department of Health and Ageing Australian Government. 2011. www.pbs.gov.au/info/about-the-pbs (accessed 14 October 2011).
45. Procedures and Resources Manual. Australian Association of Consultant Pharmacy. 2011. www.aacp.com.au/FourpointRoot/portal/shared/Assets/mmr-manual- 09/AACP-Manual-2009-Ch10.pdf (accessed 14 October 2011).
46. O'Halloran J, et al,. Older Patients Attending General Practice in Australia 2000-02. General Practice Series No. 12, General Practice Statistics and Classification Unit. Australian Institute of Health and Welfare 1-147, Canberra. 2003. www.aihw.gov.au/publications/index.cfm/title/9208 (accessed 14 October 2011).
47. Department of Health and Ageing, Australian Government. Expenditure and Prescriptions Twelve Months to 30 June 2009. 2009. www.health.gov.au/internet/ main/publishing.nsf/Content/696CBFCEB2FFD713CA257679000EABCA/$File/ Expenditure%20and%20Prescirption%202009.pdf (accessed 14 October 2011).
48. Australian Institute of Health and Welfare. 2006. Australia's Health 2006. www.aihw.gov.au/publications/index.cfm/title/10321 (accessed 14 October 2011).
49. eMIMs for Pharmacy. 2011. Homepage on the internet. CMPMedicaPty Ltd Sydney NSW. www.mims.com.au (accessed 14 October 2011).
50. Thomson Reuters (Healthcare). Drug-Reax System. 2011. Internet database, updated periodically. Greenwood Village, CO: Thomson Reuters (Healthcare).
51. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification System Index with Defined Daily Doses (DDDs). Oslo: World Health Organization. 2011. www.whocc.no/atc-ddd-index/ (accessed 14 October 2011).
52. World Health Organization. International Statistical Classification of Disease and Related Health Problems, 10th revision. Geneva: World Health Organization. 2011. http://apps.who.int/classifications/apps/icd/icd10online/ (accessed 14 October 2011).
53. Garcia-Caballos M, et al,. Drug-related problems in older people after hospital discharge and interventions to reduce them. Age Ageing 2010; 39: 430-438.
54. Australian Pharmaceutical Advisory Council. Commonwealth of Australia. Guiding Principles to Achieve Continuity in Medication Management. 2005. www.health.gov.au/internet/main/publishing.nsf/Content/ 4182D79CFCB23CA2CA25738E001B94C2/$File/guiding.pdf (accessed 14 October 2011).
55. Guthrie B, et al,. The burden of psychotropic drug prescribing in people with dementia: a population database study. Age Ageing 2010; 39: 637-642.
56. The Pharmaceutical Society of Australia. The Australian Pharmaceutical Formulary and Handbook, 21st edn. Canberra: The Pharmaceutical Society of Australia, 2009.
57. Viktil KK, et al,. Comparison of drug-related problems in different patient groups. Ann Pharmacother 2004; 38: 942-948.
58. Triller DM, et al,. Resolution of drug-related problems in home care patients through a pharmacy referral service. Am J Health Syst Pharm 2003; 60: 905-910.
59. Eichenberger PM, et al,. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci 2010; 33: 362-372.
60. Bell JS, et al,. Drug-related problems in the community setting. Clin Drug Invest 2006; 26: 415-425.
61. Roughead EE, et al,. Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf 2004; 13: 83-87.
62. Van Mil JWF, et al,. Drug-Related Problem Classification Systems. Ann Pharmacother 2004; 38: 859-867.
63. Bjorkman IK, et al,. Comparing 4 classification systems for drug-related problems: Processes and functions. Res Social Adm Pharm 2008; 4: 320-331.
64. National Institute of Clinical Studies, Australian Government. Evidence-Practice Gaps Report, vol. 1. 2003. www.nhmrc.gov.au/nics/material- resources/resources/evidence-volume-one.htm (accessed 14 October 2011).
65. National Institute of Clinical Studies, Australian Government. Evidence-Practice Gaps Report, vol. 2. 2005. www.nhmrc.gov.au/nics/material- resources/resources/evidence-volume-two.htm (accessed 14 October 2011).
66. National Institute of Clinical Studies, Australian Government. Evidence-Practice Gaps Report, vol. 1. A Review of Developments 2004-2007. 2008. http://www.nhmrc.gov.au/nics/materials-and-resources/evidencepractice-gaps- report-volume-onereview-developments-2004-2007 (accessed 15 October 2011).
67. Wright RM, et al,. Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: results of a cross-sectional analysis of data from the geriatric evaluation and management drug study. Am J Geriatr Pharmacother 2009; 7: 271-280.
68. McLeod PJ, et al,. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156: 385-391.
69. Hanlon JT, et al,. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045-1051.
70. Naugler CT, et al,. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 2000; 7: 103-107.
71. Lund BC, et al,. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 2010; 44: 957-963.
72. Zermansky AG, et al,. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323: 1-5.
73. Bochner F,. Australian Medicines Handbook Drug Choice Companion: Aged Care, 3rd edn. Adelaide: Australian Medicines Handbook Pty, 2010.
74. Alpert JS,. A review of clinical guidelines with some thoughts about their utility and appropriate use. Am J Med 2010; 123: 573-576.
75. Webster RJ, et al,. Gaps in cardiovascular disease risk management in Australian general practice. Med J Aust 2009; 191: 324-329.
76. Shakib S, et al,. What we have here is a failure to communicate! Improving communication between tertiary care for chronic heart failure patients. Intern Med J 2009; 39: 595-599.
77. Brand C, et al,. Measuring performance to drive improvement: development of a clinical indicator set for general practice. Intern Med J 2009; 39: 361-369.
78. Barker A, et al,. Pharmacist directed home medication reviews in patients with chronic heart failure: a randomised trial. Int J Cardiol 2011 (in press).
79. Royal S, et al,. Interventions in primary care to reduce medication related adverse events and hospital admissions; systematic review and meta-analysis. Qual Saf Health Care 2006; 15: 23-31.
80. Holland R, et al,. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol 2007; 65: 303-316.
81. Krska J, et al,. Pharmacist-led medication review in patients over 65: a randomised, controlled trial in primary care. Age Ageing 2001; 30: 205-211.
82. Niquille A, Bugnon O,. Relationship between drug-related problems and health outcomes: a cross-sectional study among cardiovascular patients. Pharm World Sci 2010; 32: 512-519.
83. Gillespie U, et al,. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older. Arch Intern Med 2009; 169: 894-900.
84. Koshman SL, et al,. Pharmacist care of patients with heart failure. Arch Intern Med 2008; 168: 687-694.
85. Roughead EE, et al,. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting. Circ Heart Fail 2009; 2: 424-428.
86. Stafford L, et al,. Clinical outcomes of a collaborative, home-based postdischarge warfarin management service. Ann Pharmacother 2011; 45: 325-334.